Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles

Biomaterials

Volumn 32, Issue 11, 2011, Pages 2979-2988

  Wang, Han ^a   Zheng, Linfeng ^a   Peng, Chen ^b   Guo, Rui ^b   Shen, Mingwu ^b   Shi, Xiangyang ^b,c   Zhang, Guixiang ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b DONGHUA UNIVERSITY   (China)

^c UNIVERSITY OF MADEIRA   (Portugal)

Author keywords

Cancer cells; Computed tomography; Dendrimers; Gold nanoparticles; Molecular imaging

Indexed keywords

CANCER CELLS; CELL CYCLE; CELL LINES; CELL MORPHOLOGY; CELL VIABILITY; COMPUTED TOMOGRAPHY; CONCENTRATION RANGES; CT IMAGING; FLOW-CYTOMETRIC ANALYSIS; GOLD NANOPARTICLES; HUMAN LUNG; IN-VITRO; INTRAPERITONEAL ADMINISTRATION; MICRO CT; MOLECULAR IMAGING; MORPHOLOGICAL OBSERVATIONS; POLYAMIDOAMINE DENDRIMERS; TUMOR MODELS;

ACETYLATION; BIOCOMPATIBILITY; BROMINE COMPOUNDS; CELL CULTURE; CELLS; DENDRIMERS; DISEASES; GOLD; NANOPARTICLES; TRANSMISSION ELECTRON MICROSCOPY;

COMPUTERIZED TOMOGRAPHY;

5 POLY(AMIDOAMINE); [3 (4,5 DIMETHYLTHIAZOL 2 YL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; DENDRIMER; EOSIN; GOLD NANOPARTICLE; HEMATOXYLIN; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; CANCER CELL; CELL CYCLE; CELL STRUCTURE; CELL VIABILITY; CHEMICAL REACTION; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION (PARAMETERS); CYTOTOXICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYSOSOME; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STAINING; TRANSMISSION ELECTRON MICROSCOPY; TUMOR XENOGRAFT; X RAY ANALYSIS;

ACETYLATION; CELL LINE, TUMOR; DENDRIMERS; GOLD; HUMANS; METAL NANOPARTICLES; NANOTECHNOLOGY; X-RAY MICROTOMOGRAPHY;

EID: 79951579300     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.01.001     Document Type: Article

References (55)

1. Deshpande N., Needles A., Willmann J.K. Molecular ultrasound imaging: current status and future directions. Clin Radiol 2010, 65:567-581.
2. Gaertner F.C., Schwaiger M., Beer A.J. Molecular imaging of αvß3 expression in cancer patients. Q J Nucl Med Mol Imag 2010, 54:309-326.
3. Garanger E., Hilderbrand S.A., Blois J.T., Sosnovik D.E., Weissleder R., Josephson L. A DNA-binding Gd chelate for the detection of cell death by MRI. Chem Commun 2009, 4444-4446.
4. Gessner R., Dayton P.A. Advances in molecular imaging with ultrasound. Mol Imaging 2010, 9:117-127.
5. Hasegawa S., Furukawa T., Saga T. Molecular MR imaging of cancer gene therapy: ferritin transgene reporter takes the stage. Magn Reson Med Sci 2010, 9:37-47.
6. Herschman H.R. Molecular imaging: looking at problems, seeing solutions. Science 2003, 302:605-608.
7. Massoud T.F., Gambhir S.S. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003, 17:545-580.
8. Penet M.F., Mikhaylova M., Li C., Krishnamachary B., Glunde K., Pathak A.P., et al. Applications of molecular MRI and optical imaging in cancer. Future Med Chem 2010, 2:975-988.
9. Pysz M.A., Gambhir S.S., Willmann J.K. Molecular imaging: current status and emerging strategies. Clin Radiol 2010, 65:500-516.
10. Vinegoni C., Feruglio P.F., Cortez-Retamozo V., Razansky D., Medoff B.D., Ntziachristos V., et al. Imaging of molecular probe activity with born-normalized fluorescence optical projection tomography. Opt Lett 2010, 35:1088-1090.
11. Weissleder R. Molecular imaging: exploring the next frontier. Radiology 1999, 212:609-614.
12. Zhu L., Niu G., Fang X., Chen X. Preclinical molecular imaging of tumor angiogenesis. Q J Nucl Med Mol Imaging 2010, 54:291-308.
13. Boisselier E., Astruc D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev 2009, 38:1759-1782.
14. Guo R., Wang H., Peng C., Shen M.W., Pan M.J., Cao X.Y., et al. X-ray attenuation property of dendrimer-entrapped gold nanoparticles. J Phys Chem C 2010, 114:50-56.
15. Melancon M., Lu W., Li C. Gold-based magneto/optical nanostructures: challenges for in vivo applications in cancer diagnostics and therapy. Mater Res Bull 2009, 34:415-421.
16. Radwan S.H., Azzazy H.M. Gold nanoparticles for molecular diagnostics. Expert Rev Mol Diagn 2009, 9:511-524.
17. Wu X., Ming T., Wang X., Wang P., Wang J., Chen J. High-photoluminescence-yield gold nanocubes: for cell imaging and photothermal therapy. ACS Nano 2010, 4:113-120.
18. Guo R., Li R., Li X., Zhang L., Jiang X., Liu B. Dual-functional alginic acid hybrid nanospheres for cell imaging and drug delivery. Small 2009, 5:709-717.
19. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new X-ray contrast agent. Br J Radiol 2006, 79:248-253.
20. Hall C.J., Schultke E., Rigon L., Ataelmannan K., Rigley S., Menk R., et al. Synchrotron-based in vivo tracking of implanted mammalian cells. Eur J Radiol 2008, 68:S156-S159.
21. Kim D., Park S., Lee J.H., Jeong Y.Y., Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 2007, 129:7661-7665.
22. Kojima C., Umeda Y., Ogawa M., Harada A., Magata Y., Kono K. X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer. Nanotechnology 2010, 21:245104.
23. Xu C.J., Tung G.A., Sun S.H. Size and concentration effect of gold nanoparticles on X-ray attenuation as measured on computed tomography. Chem Mater 2008, 20:4167-4169.
24. Hubbell J.H., Seltzer S.M. Tables of X-Ray mass attenuation coefficients and mass energy-absorption coefficients from 1 keV to 20 MeV for elements Z = 1 to 92 and 48 additional substances of dosimetric interest 2009, Online, Available from. http://www.nist.gov/pml/data/xraycoef/index.cfm.
25. Connor E.E., Mwamuka J., Gole A., Murphy C.J., Wyatt M.D. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1:325-327.
26. Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005, 21:10644-10654.
27. Byrne J.D., Betancourt T., Brannon-Peppas L. Active targeting schemes for nanoparticle systems in cancer therapeutics. Adv Drug Deliv Rev 2008, 60:1615-1626.
28. Marchal F., Pic E., Pons T., Dubertret B., Bolotine L., Guillemin F. Quantum dots in oncological surgery: the future for surgical margin status?. Bull Cancer 2008, 95:1149-1153.
29. Patra C.R., Bhattacharya R., Mukhopadhyay D., Mukherjee P. Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer. Adv Drug Deliver Rev 2010, 62:346-361.
30. Popovtzer R., Agrawal A., Kotov N.A., Popovtzer A., Balter J., Carey T.E., et al. Targeted gold nanoparticles enable molecular CT Imaging of cancer. Nano Lett 2008, 8:4593-4596.
31. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000, 65:271-284.
32. Tomalia D.A., Frechet J.M.J. Dendrimers and other dendritic polymers 2001, John Wiley & Sons Ltd, New York.
33. Peng C., Wang H., Guo R., Shen M., Cao X., Zhang G.X., et al. Acetylation of dendrimer-entrapped gold nanoparticles: synthesis, stability, and X-ray attenuation property. J Appl Polym Sci 2010, 119:1673-1682.
34. Shi X., Wang S., Sun H., Baker J.R. Improved biocompatibility of surface functionalized dendrimer-entrapped gold nanoparticles. Soft Matter 2007, 3:71-74.
35. Shi X., Wang S., Meshinchi S., Van Antwerp M.E., Bi X., Lee I.H., et al. Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 2007, 3:1245-1252.
36. Shi X., Lee I., Baker J.R. Acetylation of dendrimer-entrapped gold and silver nanoparticles. J Mater Chem 2008, 18:586-593.
37. Shen M., Shi X. Dendrimer-based organic/inorganic hybrid nanoparticles in biomedical applications. Nanoscale 2010, 2:1027-1032.
38. Shen M., Sun K., Shi X. Hydroxylated dendrimer-stabilized gold and silver nanoparticles: spontaneous formation, characterization, and surface properties. Curr Nanosci 2010, 6:307-314.
39. Shi X., Wang S.H., Van Antwerp M.E., Chen X., Baker J.R. Targeting and detecting cancer cells using spontaneously formed multifunctional dendrimer-stabilized gold nanoparticles. Analyst 2009, 134:1373-1379.
40. Shi X., Ganser T.R., Sun K., Balogh L.P., Baker J.R. Characterization of crystalline dendrimer-stabilized gold nanoparticles. Nanotechnology 2006, 17:1072-1078.
41. Shi X., Sun K., Baker J.R. Spontaneous formation of functionalized dendrimer-stabilized gold nanoparticles. J Phys Chem C 2008, 112:8251-8258.
42. Hong S., Bielinska A.U., Mecke A., Keszler B., Beals J.L., Shi X., et al. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug Chem 2004, 15:774-782.
43. Majoros I.J., Keszler B., Woehler S., Bull T., Baker J.R. Acetylation of poly(amidoamine) dendrimers. Macromolecules 2003, 36:5526-5529.
44. Shi X., Wang S.H., Lee I., Shen M., Baker J.R. Comparison of the internalization of targeted dendrimers and dendrimer-entrapped gold nanoparticles into cancer cells. Biopolymers 2009, 91:936-942.
45. Kim D., Jeong Y.Y., Jon S. A drug-loaded aptamer-gold nanoparticle bioconjugate for combined CT imaging and therapy of prostate cancer. ACS Nano 2010, 4:3689-3696.
46. Zhang Z.W., Jia J., Lai Y.Q., Ma Y.Y., Weng J.A., Sun L.P. Conjugating folic acid to gold nanoparticles through glutathione for targeting and detecting cancer cells. Bioorg Med Chem 2010, 18:5528-5534.
47. Yang H., Zhang C., Shi X., Hu H., Du X., Fang Y., et al. Water-soluble superparamagnetic manganese ferrite nanoparticles for magnetic resonance imaging. Biomaterials 2010, 31:3667-3673.
48. Lesniak W., Bielinska A.U., Sun K., Janczak K.W., Shi X., Baker J.R., et al. Silver/dendrimer nanocomposites as biomarkers: fabrication, characterization, in vitro toxicity, and intracellular detection. Nano Lett 2005, 5:2123-2130.
49. Smith J.A., Martin L. Do cells cycle?. Proc Natl Acad Sci U S A 1973, 70:1263-1267.
50. Dolbeare F., Gratzner H., Pallavicini M.G., Gray J.W. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci U S A 1983, 80:5573-5577.
51. Kajstura M., Halicka H.D., Pryjma J., Darzynkiewicz Z. Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete "sub-G1" peaks on DNA content histograms. Cytom Part A 2007, 71:125-131.
52. Greish K. Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target 2007, 15:457-464.
53. Greish K. Enhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targeting. Methods Mol Biol 2010, 624:25-37.
54. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 2010, 21:797-802.
55. Maeda H., Bharate G.Y., Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect. Eur J Pharm Biopharm 2009, 71:409-419.